Painchek Ltd (PCK) - Total Assets
Based on the latest financial reports, Painchek Ltd (PCK) holds total assets worth AU$7.63 Million AUD (≈ $5.40 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Painchek Ltd - Total Assets Trend (2011–2026)
This chart illustrates how Painchek Ltd's total assets have evolved over time, based on quarterly financial data. Also see Painchek Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Painchek Ltd - Asset Composition Analysis
Current Asset Composition (June 2026)
Painchek Ltd's total assets of AU$7.63 Million consist of 99.7% current assets and 0.3% non-current assets. Review Painchek Ltd (PCK) total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 78.6% |
| Accounts Receivable | AU$1.53 Million | 20.1% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2011–2026)
This chart illustrates how Painchek Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See PCK stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Painchek Ltd's current assets represent 99.7% of total assets in 2026, an increase from 88.6% in 2011.
- Cash Position: Cash and equivalents constituted 78.6% of total assets in 2026, down from 82.1% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 20.1% of total assets.
Painchek Ltd Competitors by Total Assets
Key competitors of Painchek Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
TRELLUS HEALTH LS -0006
F:85Q
|
Germany | €9.22 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
|
Intrasense
PA:ALINS
|
France | €7.99 Million |
|
Trivarx Ltd
AU:TRI
|
Australia | AU$16.53 Million |
|
HITIQ Ltd
AU:HIQ
|
Australia | AU$3.28 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
Painchek Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.99 | 0.65 | 3.31 |
| Quick Ratio | 0.99 | 0.65 | 3.29 |
| Cash Ratio | 0.00 | 0.00 | 3.20 |
| Working Capital | AU$-63.48K | AU$-1.13 Million | AU$8.23 Million |
Painchek Ltd - Advanced Valuation Insights
This section examines the relationship between Painchek Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.81 |
| Latest Market Cap to Assets Ratio | 2.23 |
| Asset Growth Rate (YoY) | 254.8% |
| Total Assets | AU$7.63 Million |
| Market Capitalization | $17.01 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Painchek Ltd's assets at a significant premium (2.23x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Painchek Ltd's assets grew by 254.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Painchek Ltd (2011–2026)
The table below shows the annual total assets of Painchek Ltd from 2011 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-06-30 | AU$7.63 Million ≈ $5.40 Million |
+254.84% |
| 2025-06-30 | AU$2.15 Million ≈ $1.52 Million |
-48.60% |
| 2024-06-30 | AU$4.18 Million ≈ $2.96 Million |
+49.62% |
| 2023-06-30 | AU$2.80 Million ≈ $1.98 Million |
-57.98% |
| 2022-06-30 | AU$6.65 Million ≈ $4.71 Million |
-43.68% |
| 2021-06-30 | AU$11.81 Million ≈ $8.36 Million |
+90.02% |
| 2020-06-30 | AU$6.22 Million ≈ $4.40 Million |
+30.87% |
| 2019-06-30 | AU$4.75 Million ≈ $3.36 Million |
+29.32% |
| 2018-06-30 | AU$3.67 Million ≈ $2.60 Million |
+36.54% |
| 2017-06-30 | AU$2.69 Million ≈ $1.90 Million |
+2245.38% |
| 2016-06-30 | AU$114.69K ≈ $81.15K |
-95.09% |
| 2015-06-30 | AU$2.34 Million ≈ $1.65 Million |
+143.45% |
| 2014-06-30 | AU$959.92K ≈ $679.20K |
-31.06% |
| 2013-06-30 | AU$1.39 Million ≈ $985.18K |
-42.59% |
| 2012-06-30 | AU$2.43 Million ≈ $1.72 Million |
+989.97% |
| 2011-06-30 | AU$222.50K ≈ $157.43K |
-- |
About Painchek Ltd
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate th… Read more